Histone deacetylase 1 regulates haloperidol-induced motor side effects in aged mice

• Published in: Behavioural brain research 2023-06, Vol.447, p.114420-114420, Article 114420
• Main Authors: McClarty, Bryan M., Chakraborty, Saikat, Rodriguez, Guadalupe, Dong, Hongxin
• Format: Article
• Language: English
• Subjects: Animals; Antipsychotic Agents - adverse effects; Antipsychotics; Drug-Related Side Effects and Adverse Reactions; Gene editing; Haloperidol - adverse effects; Histone deacetylase 1 (HDAC1); Histone Deacetylase 1 - metabolism; Histone Deacetylase Inhibitors - pharmacology; Mice; Motor side effects
• ISSN: 0166-4328; 1872-7549
• DOI: 10.1016/j.bbr.2023.114420

Antipsychotic drugs prescribed to elderly patients with neuropsychiatric disorders often experience severe extrapyramidal side effects. Previous studies from our group suggest that changes in histone modifications during aging increase the risk for antipsychotic drug side effects, because co-administration of antipsychotics with class 1 histone deacetylase (HDAC) inhibitors could mitigate the severity of motor side effects in aged mice. However, which HDAC subtype contributes to the age-related sensitivity to antipsychotic drug side effects is unknown. In this study, we overexpressed histone deacetylase type 1(HDAC1) in the striatum of 3-month-old mice and knocked down HDAC 1 in the striatum of 21-month-old mice by microinjection of AAV9-HDAC1-GFP or AAV9-CRISPR/Cas9-HDAC1-GFP vectors. Four weeks after the viral-vector delivery, the typical antipsychotic drug haloperidol was administered daily for 14 days, followed by motor function assessments through the open field, rotarod, and catalepsy behavioral tests. Young mice with overexpressed HDAC1 showed increased cataleptic behavior induced by haloperidol administration, which is associated with the increased HDAC1 level in the striatum. In contrast, aged mice with HDAC1 knocked down rescued locomotor activity, motor coordination, and decreased cataleptic behavior induced by haloperidol administration, which is associated with decreased HDAC1 level in the striatum. Our results suggest that HDAC1 is a critical regulator in haloperidol-induced severe motor side effects in aged mice. Repression of HDAC1 expression in the striatum of aged mice could mitigate typical antipsychotic drug-induced motor side effects.